- Merck, Gilead report mixed outcomes in key lung cancer, HIV studies<figure><div><img src="https://imgproxy.divecdn.com/lM3CYabLlmazQYt-COfrxYzxdsO20VnU3PS1vfCq2lE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjEwOTMxMjkxXzEua…BioPharma Dive · 1mo ago↗ source
- Stealthy startup Treeline plans a reverse merger<figure><div><img src="https://imgproxy.divecdn.com/zFaUfmdVIipdm_YpQNEDluIv-xqM-1mOqftBuOls6_g/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9UcmVlTGluZV8xMDAuanBn.webp"/></div…BioPharma Dive · 1mo ago↗ source
- GSK boosts cancer pipeline with $11B Nuvalent buyout<figure><div><img src="https://imgproxy.divecdn.com/mDk-h3NLB8udDPFuDlI7IPou1i9tJKJYucQXUnhK9vA/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc3MzEzMjc4LmpwZ…